Mesoblast (MSB) News Today → Biden replacement revealed? (From Paradigm Press) (Ad) Free MSB Stock Alerts Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadline9 ASX All Ords shares elevated to 'strong buy' status in Aprilmsn.com - May 2 at 12:50 AMIf you invested $6,000 in Mesoblast shares a month ago you'd have $15,636 now!fool.com.au - April 23 at 2:11 AMWhy the Mesoblast share price can rise another 60%msn.com - April 5 at 12:01 AMTop 5 Health Care Stocks That May Plunge In Marchmsn.com - March 28 at 10:09 AMAfter Almost 4 Years, FDA Says Mesoblast Phase 3 Therapy Data Can Support Resubmission For Serious Complications in Children Following Stem Cell Transplantfinance.yahoo.com - March 27 at 2:46 AMMesoblast gains as FDA backs regulatory plans for cell therapymsn.com - March 26 at 8:08 AMMESO Mar 2024 3.000 putfinance.yahoo.com - March 15 at 8:59 AMWhy is the Mesoblast share price jumping 16% on Monday?msn.com - March 11 at 1:00 AMMesoblast : FDA Backs Accelerated Approval For Rexlemestrocel-L In Heart Failure Patientsmarkets.businessinsider.com - March 11 at 1:00 AMAustralia stocks higher at close of trade; S&P/ASX 200 up 0.39%msn.com - March 7 at 2:29 AMMESO Mar 2024 2.000 putfinance.yahoo.com - February 17 at 8:52 AMWhat investors can learn from analysing R&D spendingafr.com - February 4 at 2:43 PMMesoblast surges on FDA ‘rare paediatric disease’ designationafr.com - January 19 at 8:41 AMIn Case You Missed It: A thing, a different thing and an amusing play on words, I guessmsn.com - January 19 at 12:31 AMMesoblast (ASX:MSB) investors are sitting on a loss of 88% if they invested three years agofinance.yahoo.com - January 8 at 8:47 PMWhy is the Mesoblast share price sinking 25% on Tuesday?fool.com.au - December 4 at 8:57 PMWhy are Mesoblast shares charging 5% higher today?fool.com.au - November 27 at 9:59 PMMesoblast Partners With Blood and Marrow Transplant Clinical Trials Network (BMT CTN) on Pivotal Trial in Adults With SR-aGVHDfinance.yahoo.com - November 21 at 11:16 PMMesabi Trust MSBmorningstar.com - November 9 at 10:16 AMWhile institutions own 25% of Mesoblast Limited (ASX:MSB), individual investors are its largest shareholders with 57% ownershipfinance.yahoo.com - November 8 at 11:09 PMMesoblast share price bleeds after chewing through $18.1 millionfool.com.au - October 31 at 7:51 AMAustralia stocks lower at close of trade; S&P/ASX 200 down 1.36%msn.com - October 20 at 8:10 AMWhen Will Mesoblast Limited (ASX:MSB) Breakeven?finance.yahoo.com - October 18 at 8:50 PMWhy is the Mesoblast share price beating the market today?fool.com.au - September 26 at 1:37 AMKey Outcomes From FDA Type A Meeting and Mesoblast Next Steps to Achieve RYONCIL Approvalfinance.yahoo.com - September 21 at 7:07 AMCANTOR FITZGERALD Maintains Mesoblast (ASX:MSB) Overweight Recommendationnasdaq.com - August 31 at 8:59 PMMesoblast share price surges 10%. What’s going on?fool.com.au - August 22 at 11:28 PMThe Secret Broker: Three hot tips to avoid the next ‘messoblast’msn.com - August 11 at 1:00 AMMesoblast share price surges 11% following horror start to Augustfool.com.au - August 10 at 12:23 AMThis $9 billion investor is selling off Mesoblast shares. Should you?fool.com.au - August 8 at 11:20 PMMesoblast shares continue slide, but this ASX biotech stock is soaring 23%!fool.com.au - August 8 at 8:18 AMWhat this broker is saying about Mesoblast shares following the sellofffool.com.au - August 6 at 7:08 PMScoPo’s Powerplays: Mesoblast sinks Health sector, and how to live 24 years longermsn.com - August 4 at 3:14 AMMesoblast: the biotech that hasn’t - yetafr.com - August 4 at 3:14 AMMesoblast share price crashes 58% after FDA blowfool.com.au - August 3 at 10:14 PMASX Health Stocks: Mesoblast crashes 54pc after FDA says it needs more data for approvalmsn.com - August 3 at 10:14 PMFDA rejects Mesoblast's cell therapy for bone marrow transplant complicationsreuters.com - August 3 at 10:14 PMMesoblast Receives Complete Response From U.S. Food and Drug Administration for Biologics License Application for Steroid-Refractory Acute Graft Versus Host Disease in Childrenfinance.yahoo.com - August 3 at 10:14 PMMesoblast share price frozen ahead of FDA newsfool.com.au - August 1 at 9:39 PMMesoblast (ASX:MSB investor three-year losses grow to 74% as the stock sheds AU$94m this past weekfinance.yahoo.com - August 1 at 9:39 PMMesoblast Stock (NASDAQ:MESO) Insider Tradesbenzinga.com - July 31 at 8:53 AMAppendix 4C Quarterly Activity Report for Quarter...benzinga.com - July 30 at 10:52 PMAppendix 4C Quarterly Activity Report for Quarter Ended June 30, 2023finance.yahoo.com - July 30 at 10:52 PMTop broker says surging Mesoblast share price still has 60% upsidefool.com.au - July 12 at 11:30 PMMesoblast Director Philip R. Krause, M.D., Appointed to Strategic Advisory Rolefinance.yahoo.com - June 4 at 9:17 PMMesoblast Limited's (ASX:MSB) largest shareholders are individual investors with 52% ownership, institutions own 31%finance.yahoo.com - June 1 at 7:37 PMMesoblast Reports Operational and Financial Highlights for Quarter Ended March 31, 2023finance.yahoo.com - May 25 at 11:55 PMWhy did the Mesoblast share price just dive 12%?msn.com - April 26 at 2:12 AMMesoblast Completes Private Placementfinance.yahoo.com - April 25 at 9:11 PMHere’s why Mesoblast shares are in a trading halt todaymsn.com - April 20 at 9:17 AM Get Mesoblast News Delivered to You Automatically Sign up to receive the latest news and ratings for MSB and its competitors with MarketBeat's FREE daily newsletter. Email Address Biden replacement revealed? (Ad)A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13. See his shocking evidence in this new report MSB Media Mentions By Week MSB Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MSB News Sentiment▼1.340.42▲Average Medical News Sentiment MSB News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MSB Articles This Week▼10▲MSB Articles Average Week Get Mesoblast News Delivered to You Automatically Sign up to receive the latest news and ratings for MSB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AGNPF News Today AKBLF News Today DRTSW News Today ARNI News Today ARTLW News Today ASCLF News Today AWKNF News Today AXIM News Today BRRGF News Today BCTXW News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:MSB) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldUrgent Nvidia WarningAltimetryGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchThe asset beating inflation by 4xColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mesoblast Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
